News & Events
Our updates
Check the latest news and information about our company and technology. Find here news about our products, services and training. Read our articles, check our latest events and clips from the press.
TERMIS – EU CHAPTER
The 2023 TERMIS EU Conference in Manchester brings together researchers, clinicians, and industry experts to share cutting-edge advances in tissue engineering and regenerative medicine
Bridging Immunity to Cancer
The interplay between immune cells and the tumor microenvironment critically shapes cancer progression. The MIVO® Immune-on-Chip provides a 3D platform to study these interactions in a controlled, physiologically relevant setting
React4life in the GlycoNoVi project for the treatment of Norovirus infection.
GlycoNoVi, a Horizon Europe Marie Skłodowska-Curie Actions Doctoral Network coordinated by the University of Florence, brings together leading academic and industrial partners to unravel the molecular mechanisms of Norovirus infection. As industrial leader, React4Life will apply its MIVO® organ-on-chip technology to model human intestinal responses and accelerate antiviral drug discovery.
React4Life is one of the founding members of the Italian Society of Organ-on-Chip
The Italian Society of Organ-on-Chip (SIOoC) unites leading academic and industrial experts to advance organ-on-chip research. React4life, among the founding members, supports this milestone initiative fostering innovation and collaboration across disciplines.
React4Life at the 20th Italian Edition of the L’Oréal-UNESCO Award “For Women in Science”
Silvia Scaglione, co-founder at React4life, presented MIVO, the patented organ-on-chip platform that mimics human physiology, enabling efficient drug testing in cancer, immunotherapy, and cardiac research, recognized at the 20th Italian L’Oréal–UNESCO Women in Science Award.